two.7 Family Office has invested in Avelios, a developer of a modular AI-driven hospital information system aimed at transforming healthcare operations in Germany.

Target Information

Avelios, a pioneering technology firm, specializes in developing a modular, cloud-based, and AI-driven hospital information system. This innovative platform aims to digitalize and efficiently integrate clinical processes, thereby enhancing healthcare delivery and operational efficiency. By creating a comprehensive "Operating System" for the healthcare sector, Avelios positions itself as a key player in transforming how healthcare providers manage information and processes.

Industry Overview in Germany

The healthcare industry in Germany is one of the largest and most advanced systems in the world, characterized by a mix of public and private providers. With a strong emphasis on technology and innovation, Germany has seen significant investments in digital health solutions. The ongoing shift towards digitalization represents a critical opportunity for companies like Avelios, as the demand for integrated health information systems continues to grow.

Germany's healthcare system is undergoing substantial reforms aimed at improving efficiency, reducing costs, and enhancing patient care quality. The increasing adoption of digital tools and electronic health record

View Source

Similar Deals

Demeter Phagos

2025

Series A Bio Therapeutic Drugs Other
China Development Industrial Bank Anbogen Therapeutics

2024

Series A Proprietary & Advanced Pharmaceuticals Other
比翼生醫 梅科科技

2024

Series A Hospitals, Clinics & Primary Care Services Other
Taiwania Capital Syncell

2024

Series A Biotechnology & Medical Research (NEC) Other
1000Farmacie 1000Farmacie

2023

Series A Telemedicine Services Other
M Ventures, Debiopharm Innovation Fund Iktos

2023

Series A Proprietary & Advanced Pharmaceuticals Other

zwei.7

invested in

Avelios

in 2025

in a Series A deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert